As the first-of-its-kind multi-application platform powered by NPS technology delivering nano-second pulses of electrical energy to non-thermally clear cells while protecting adjacent non-cellular ...
Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced ...
Company’s proprietary system used to treat initial five patients in first-in-human feasibility study for patients with atrial fibrillation HAYWARD, Calif.--(BUSINESS WIRE)-- Pulse Biosciences, Inc.
A novel method uses bursts of nanosecond duration electric pulses to open the blood-brain barrier as a potential therapy for brain cancer and neurological disorders. The Vascular Enabled Integrated ...
A single-shot nanosecond pulsed field ablation catheter safely achieves high rates of acute and durable pulmonary vein isolation in PAF.
Pulse Lavage Market Size, Share, Global Trends And Industry Analysis By 2033. Pulse Lavage Market Size The global pulse ...
HAYWARD, Calif.--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, today announced that the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results